Term
|
Definition
| +, short direct acting, PSmimetic |
|
|
Term
|
Definition
| +, long direct acting PSmimetic |
|
|
Term
|
Definition
| +, long direct acting PSmimetic |
|
|
Term
|
Definition
| +, long direct acting PSmimetic |
|
|
Term
|
Definition
| natural, direct acting, PSmimetic |
|
|
Term
|
Definition
| + natural, direct acting, PSmimetic |
|
|
Term
|
Definition
| +, reversible short acting, anticholinesterase |
|
|
Term
|
Definition
| reversible, natural, longer acting, anticholinesterase |
|
|
Term
|
Definition
| +, reversible longer acting, anticholinesterase |
|
|
Term
|
Definition
| +, reversible longer acting, anticholinesterase |
|
|
Term
| DFP, isofluorophate, organophosphate |
|
Definition
| irreversible anticholinesterase |
|
|
Term
|
Definition
| in small doses, ganglionic agonist. in large doses, ganglionic antagonist |
|
|
Term
|
Definition
|
|
Term
|
Definition
| natural competitive M blocker |
|
|
Term
|
Definition
| natural competitive M blocker |
|
|
Term
|
Definition
| synthetic competive M blocker (some ganglionic blocking activity) |
|
|
Term
|
Definition
| +, synthetic competive M blocker (some ganglionic blocking activity) |
|
|
Term
|
Definition
| +, synthetic competive M blocker (some ganglionic blocking activity) |
|
|
Term
|
Definition
| synthetic competive M blocker (some ganglionic blocking activity) |
|
|
Term
|
Definition
| synthetic competive M blocker (some ganglionic blocking activity) |
|
|
Term
|
Definition
| exogenous, catecholamine, direct on alpha's, some beta1 |
|
|
Term
|
Definition
| exogenous, catecholamine, direct on all A's and B's |
|
|
Term
|
Definition
| catecholamine, direct on B's |
|
|
Term
|
Definition
| exogenous, catecholamine, direct on all A's and B's and DA (dilate renal vessels) |
|
|
Term
|
Definition
| catecholamine- direct on B1 |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| indirect, increased NE release, easily cross BBB |
|
|
Term
|
Definition
| indirect, increased NE release |
|
|
Term
|
Definition
| indirect, increased NE release, easily cross BBB |
|
|
Term
|
Definition
| indirect, decreased uptake of NE |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| blocks all A, competitive, short |
|
|
Term
|
Definition
| blocks all A's, irreversible |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| blocks both B's (least lipophilic) |
|
|
Term
|
Definition
| cardioselective, blocks B1, (B2 at high dose) |
|
|
Term
|
Definition
| cardioselective, blocks B1, (B2 at high dose) |
|
|
Term
|
Definition
| cardioselective, blocks B1, (B2 at high dose) |
|
|
Term
|
Definition
| vasodilator- A and B blocker |
|
|
Term
|
Definition
| partial B agonist (acitivty depends on state) |
|
|
Term
|
Definition
| partial B agonist, activity depends on state |
|
|
Term
|
Definition
| natural, competitive, non depol NMJ blocker (20 minutes), reversed by anticholinesterase |
|
|
Term
|
Definition
| competive, non depol NMJ blocker (hour), reversed by anticholinesterase |
|
|
Term
|
Definition
| competive, non depol NMJ blocker (hour), reversed by anticholinesterase |
|
|
Term
|
Definition
| depolarizing, NMJ blocker anticholinesterase doesn’t help (minutes) |
|
|
Term
|
Definition
| Ach release inhibitor, irreversible paralysis, sx's releived after new ones made |
|
|
